Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiran Mazumdar-Shaw Insider Profile
4 Followers
Kiran Mazumdar-Shaw, Director, Ten Percent Owner at Bicara Therapeutics Inc., holds 6.28M shares in Bicara Therapeutics Inc. (Ticker: BCAX).
Kiran Mazumdar-Shaw has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kiran Mazumdar-Shaw's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Kiran Mazumdar-Shaw holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw's Trading History
List of latest transactions for each holding click on a transaction to see Kiran Mazumdar-Shaw's performance on stock
You May Also Like
Kiran Mazumdar-Shaw insider profile FAQ
What is the percentage of profitable transactions made by Kiran Mazumdar-Shaw?
The percentage of profitable transactions made by Kiran Mazumdar-Shaw is ―.
What is the average return per transaction made by Kiran Mazumdar-Shaw?
The average return per transaction made by Kiran Mazumdar-Shaw is ―.
What stocks does Kiran Mazumdar-Shaw hold?
Kiran Mazumdar-Shaw holds: BCAX stocks.
What was Kiran Mazumdar-Shaw’s latest transaction?
Kiran Mazumdar-Shaw latest transaction was an Uninformative Buy of ―.
What was Kiran Mazumdar-Shaw's most profitable transaction?
Kiran Mazumdar-Shaw’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kiran Mazumdar-Shaw's role in Bicara Therapeutics Inc.?
Kiran Mazumdar-Shaw's role in Bicara Therapeutics Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.